Straumann Holding AGXSWX:STMN +1.81%99 PEG Ratio is 2.05 as of Jun. 26, 2026, which is 15% below its 10-year median of 2.40. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 51.92% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Straumann Holding AG's PEG Ratio or its related term are showing as below:
XSWX:STMN'
s PEG Ratio Range Over the Past 10 Years
Min: 1.1 Med: 2.4 Max: 8.2
Current: 2.05
During the past 13 years, Straumann Holding AG's highest PEG Ratio was 8.20. The lowest was 1.10. And the median was 2.40.
XSWX:STMN's PEG Ratio is ranked worse than 51.92% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.915
vs XSWX:STMN: 2.05
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Straumann Holding AG (XSWX:STMN) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Straumann Holding AG PEG Ratio Related Terms
Straumann Holding AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: PEG Ratio Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Straumann Holding AG (XSWX:STMN) has a PEG Ratio of 2.05 as of Jun. 26, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Straumann Holding AG and its competitors. This is 15% below median its historical median of 2.40. Over the past decade, Straumann Holding AG's PEG Ratio has ranged from 1.10 to 8.20. According to the industry distribution chart, Straumann Holding AG ranks #108 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 51.9%.
Is Straumann Holding AG's PEG Ratio too high?
Straumann Holding AG's current PEG Ratio of 2.05 is 15% below median its 10-year median of 2.40. Over the past 10 years, this metric has ranged from a low of 1.10 to a high of 8.20. The Medical Devices & Instruments industry median PEG Ratio is 1.92. Straumann Holding AG's value of 2.05 is 7% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #108 out of 208 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #108 out of 208 companies for PEG Ratio. This places Straumann Holding AG in the lower half of its industry. The industry median PEG Ratio is 1.92. Straumann Holding AG's value of 2.05 is 7% above this benchmark. Historically, Straumann Holding AG's own PEG Ratio has ranged from 1.10 to 8.20 over the past decade. While the company's 10-year median is 2.40 vs. the industry median of 1.92, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.92, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current PEG Ratio of 2.05 is 7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current PEG Ratio is 2.05, which is 15% below median its own 10-year median of 2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current PEG Ratio is 2.05, which is 15% below median its 10-year median of 2.40 and 7% above the Medical Devices & Instruments industry median of 1.92. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current PEG Ratio is 2.05 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
PEG Ratio: 2.05 (15% below median its 10-year median of 2.40)
GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
Industry Position: 7% above the Medical Devices & Instruments median (#108 of 208)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
